Association between recurrent acute anterior uveitis and ankylosing spondylitis
Recurrent acute anterior uveitis and ankylosing spondylitis
DOI:
https://doi.org/10.52442/jrmi.v11i2.650Keywords:
Acute Anterior Recurrent Uveitis, Ankylosing Spondylitis, Incidence, Recurrence, UveitisAbstract
Introduction: Anterior uveitis stands out as the most frequently encountered extra articular findings of ankylosing spondylitis (AS). Anterior uveitis associated with AS is frequently encountered as acute anterior recurrent uveitis (AARU).
Objective: To analyze the association between recurrent acute anterior uveitis and the subsequent incidence of ankylosing spondylitis.
Materials and Methods: This retrospective study was conducted in the Department of Ophthalmology and Orthopedics at Akbar Niazi Teaching Hospital, Islamabad Pakistan, from January 2018 to February 2023. AS patients with newly diagnosed acute anterior recurrent uveitis (AARU) (n=200) and matched control subjects without uveitis (n=200) were included in the study. AARU was diagnosed consecutively at 120-day intervals and managed with local or systemic steroids. AS incidence rates were based on the frequency of uveitis episodes, and incidence ratio were determined using the rate of incidence in control group as a reference. Data analyses were conducted using SPSS v 25.
Results: AS rate of incidence after first uveitis episode was 40.6, compared to 5.6 in control group (IRR 3.7; 95% CI, 2.5–5.5). After second episode, increased IRR to 8.9 (95% CI, 5.2–15.0). In male patients with AARU, the incidence rates of AS were 94.7 per person year. In patients ≤ 40 years old, the IRR of AARU was 15.6 (95% CI, 6.5–37.2). In patients aged ≥ 60 years, the incidence of AS in AARU did not differ from the control group.
Conclusion: The subsequent AS risk increased with frequency of acute anterior recurrent uveitis episodes. This analysis could help establish an importance for additional evaluation for potential systemic association in AARU.
References
Whitcup SM. Clinical Examination of the Patient with Uveitis. Whitcup and Nussenblatt's Uveitis: Fundamentals and Clinical Practice. 2021:31. doi: 10.1016/B978-0-323-48014-7.00003-8.
Dammak A, Huete-Toral F, Carpena-Torres C, Martin-Gil A, Pastrana C, Carracedo G. From oxidative stress to inflammation in the posterior ocular diseases: diagnosis and treatment. Pharmaceutics. 2021;13(9):1376. doi: 10.3390/pharmaceutics13091376.
Boel A, López-Medina C, van der Heijde DM, van Gaalen FA. Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study. Rheumatology. 2022;61(4):1468-1475. doi: 10.1093/rheumatology/keab544.
El Ouardi N, Djossou JH, Taoubane L, Ghassem MA, Toufik H, Majjad A, et al. Extra-articular manifestations in patients with ankylosing spondylitis: baseline characteristics from the RBSMR study. Mediterr J Rheumatol. 2022;33(3):316-321. doi: 10.31138/mjr.33.3.316.
Wong OM, Tsang HH, Chan SC, Lee KH, Li PH, Lau CS, et al. Clinical Associations of Uveitis in Axial Spondyloarthritis Group and Ankylosing Spondylitis Group: Do They Represent the Same Disease? JCR: J Clin Rheumatol. 2020;26(1):1-6. doi: 10.1097/RHU.0000000000000869.
Citera G, Bautista-Molano W, Peláez-Ballestas I, Azevedo VF, Perich RA, Méndez-Rodríguez JA, et al. Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis. Adv Rheumatol. 2021;61(2):1-12. doi: 10.1186/s42358-020-00161-5.
Oh BL, Lee JS, Lee EY, Lee HY, Yu HG. Recurrent anterior uveitis and subsequent incidence of ankylosing spondylitis: a nationwide cohort study from 2002 to 2013. Arthritis Res Ther. 2018;20(2):1-7. doi: 10.1186/s13075-018-1522-2.
Gevorgyan O, Riad M, Sarran RD, Merrill PT, Block JA, Castrejon I. Anterior uveitis in patients with spondyloarthropathies in a single US academic center: a retrospective study. Rheumatol Int. 2019; 39:1607-14. doi: 10.1007/s00296-019-04386-6.
Ahn SM, Kim M, Kim YJ, Lee Y, Kim YG. Risk of acute anterior uveitis in ankylosing spondylitis according to the type of tumor necrosis factor-alpha inhibitor and history of uveitis: a nationwide population-based study. J Clin Med. 2022;11(3):631. doi: 10.3390/jcm11030631.
Van Gelder RN, Sen HN, Tufail A, Lee AY. Here comes the SUN (Part 2): standardization of uveitis nomenclature for disease classification criteria. Am J Ophthalmol. 2021;228(8): A2-6. doi: 10.1016/j.ajo.2021.05.006.
Joltikov KA, Lobo-Chan AM. Epidemiology and risk factors in non-infectious uveitis: a systematic review. Front Med. 2021; 8: 695904. doi: 10.3389/fmed.2021.695904.
Neves LM, Haefeli LM, Hopker LM, Ejzenbaum F, Moraes do Nascimento H, Aikawa N, et al. Monitoring and treatment of juvenile idiopathic arthritis-associated uveitis: Brazilian evidence-based practice guidelines. Ocul Immunol Inflamm. 2022; 30(6): 1384-1398.
doi: 10.1080/09273948.2021.1876886.
Nguyen AT, Koné-Paut I, Dusser P. Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients. Pediatr Drugs. 2024;26(1):31-47. doi: 10.1007/s40272-023-00596-5.
Shabrina NF, Hermawan D, Montana R. Cataract Extraction on One Seeing Eye in Patient with Behcet's Disease. Ann Mechnikov's Institute. 2020;21(4):83-87.
Leclercq M, Desbois AC, Domont F, Maalouf G, Touhami S, Cacoub P, et al. Biotherapies in uveitis. J Clin Med. 2020;9(11):3599. doi: 10.3390/jcm9113599.
Jaffe GJ, Pavesio CE, Study Investigators. Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results. Ophthalmology. 2020;127(10):1395-1404. doi: 10.1016/j.ophtha.2020.04.001.
Khan HA, Khan QA, Shahzad MA. Uveitis in spondyloarthropathies. Med Hypothesis Discov Innov Optom. 2022;3(3):75-85. doi: 10.51329/mehdioptometry155.
Rosenbaum JT, Dick AD. The eyes have it: a rheumatologist’s view of uveitis. Arthritis Rheumatol. 2018;70(10):1533-1543. doi: 10.1002/art.40568.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
